Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/11/2012
BMI Releases Forecast for the Third Quarter of This Year
7/10/2012
Recent Executive Moves
7/10/2012
New Boss of Shanghai Pharma Speculated
7/9/2012
Walvax Acquires Majority Control of Shanghai Fengmao Biotech for Entry...
7/9/2012
China Increases Its Activity in Regulated Markets
7/6/2012
ShangPharma Chairman Offers to Take the Company Private
7/6/2012
Analysts Expects Renewed Pharma Industry Growth in the Second Half
7/4/2012
BMS Acquires Amylin as GSK Extends Offer for Human Genome Sciences
7/4/2012
Beike Biotech Reports Effectiveness of Stem Cell Treatment for PBC
7/4/2012
Emerging Lessons from the Emerging Markets (External)
7/4/2012
Pfizer and Hisoar Enter into 20-Year Supply Agreement for Clindamycin
7/4/2012
Pharma Gets Social: China - Pharma's Social Media Frontier (External)
7/4/2012
Recent Executive Moves
7/3/2012
Pharma Industry Performance Up Considerably in the First Five Months
7/2/2012
MOHRSS Releases 2011 Statistics for HR and Social Security Development
7/2/2012
SFDA Seeks Comments on Draft Rule on Risk Assessment for Onsite Inspec...
7/2/2012
CMOs and Final Dosage Manufacturing in China (External)
6/29/2012
Chinese Government to Fund New Drug Innovation with CNY 115B by 2020
6/29/2012
Recent Executive Moves
6/28/2012
Nanjing Pharma and Alliance Boots Extends Expiration Date of LOI
6/28/2012
Schizophrenia Prevalence Highlighted at XiAn Janssen's Invega Sustenna...
6/28/2012
NAOC: Drug Sales Margins at County Level Hospital Far Exceed 15%
6/27/2012
Use of Biologic Agents Bottlenecked in China by Under-reimbursement
6/27/2012
MIIT to Push for Consolidation of Essential Drug Manufacturing as Indu...
6/27/2012
China Selects 311 Counties as Public Hospital Reform Trial Sites
6/27/2012
Three Pharma Industry Programs to Receive Central Government Funding S...
6/26/2012
Leading Chinese Pharma Cos Jointly Set Up Healthcare Investment Fund
6/25/2012
MOFCOM: Delayed Hospital Drug Payments Undermine Drug Quality and R&am...
6/25/2012
TaiGen and Zhejiang Medicine Sign Licensing Agreement for Nemonoxacin
6/22/2012
Gentris and SIPM to Collaborate in Biomarker Research
Page:
253
/
333
Total number of articles:
9989
:
[First]
[<<]
[251]
[252]
[253]
[254]
[255]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit